Burning Rock Biotech Limi...

NASDAQ: BNR · Real-Time Price · USD
7.17
0.22 (3.17%)
At close: Aug 15, 2025, 9:53 AM

Burning Rock Biotech Income Statement

Financials in CNY. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
133.08M 126.02M 128.64M 135.53M 125.62M 121.08M 127.57M 146.27M 142.52M 142.24M 154.63M 130.85M 135.52M 147.34M 126.61M 127.28M 106.62M
Cost of Revenue
35.68M 36.6M 36.8M 40.09M 39.93M 42.97M 41.65M 45.85M 43.74M 40.97M 46.04M 48.24M 47.94M 41.97M 35.02M 37.05M 29.68M
Gross Profit
97.4M 89.42M 91.85M 95.44M 85.69M 78.11M 85.92M 100.42M 98.77M 101.26M 108.59M 82.6M 87.58M 105.38M 91.6M 90.23M 76.94M
Operating Income
-15.18M -81.93M -38.59M -111.22M -125.83M -166.32M -178.81M -135.72M -188.46M -217.44M -234.64M -265.46M -262.86M -252.13M -171.04M -202.03M -171.86M
Interest Income
2.58M 1.81M 3.17M 3.19M 4.04M 5.54M 4.02M 5.25M 3.14M 2.84M 2.01M 2.69M 1.95M 1.03M 958K 681K 787K
Pretax Income
-13.28M -75.98M -35.54M -107.85M -121.37M -161.14M -174.53M -130.8M -184.83M -214.32M -231.48M -262.05M -261.39M -252.29M -170.05M -202.04M -171.41M
Net Income
-13.5M -81.29M -35.74M -108.04M -121.55M -162.21M -174.98M -131.24M -185.25M -216.22M -226.31M -262.14M -257.96M -251.14M -170.48M -203.66M -171.41M
Selling & General & Admin
72.19M 84.02M 81.28M 141.7M 145.54M 171.32M 181.03M 140.37M 192.81M 217.88M 233.81M 255.95M 230.94M 244.78M 192.99M 184.19M 171.39M
Research & Development
40.39M 52.2M 49.15M 64.95M 65.98M 73.12M 83.7M 95.78M 94.42M 100.83M 109.43M 92.11M 119.5M 112.72M 69.65M 108.07M 77.41M
Other Expenses
n/a 35.13M n/a n/a 434K 160K -157K -118K 599K -84K -189K 127K 298K -372K 20K 433K 118K
Operating Expenses
112.58M 171.35M 130.44M 206.65M 211.52M 244.44M 264.74M 236.15M 287.23M 318.71M 343.24M 348.06M 350.44M 357.51M 262.64M 292.26M 248.8M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 29K 1.95M 94K 367K 565K 510K
Selling & Marketing Expenses
40.89M 46.73M 48.41M 48.91M 46.86M 49.78M 62.31M 70.84M 64.77M 85.17M 90.28M 105.63M 89.21M 103.22M 76.69M 68.06M 55.13M
Cost & Expenses
148.26M 207.95M 167.23M 246.75M 251.45M 287.41M 306.38M 281.99M 330.97M 359.68M 389.27M 396.31M 398.38M 399.47M 297.66M 329.31M 278.49M
Income Tax Expense
224K 5.31M 201K 190K 180K 1.07M 450K 445K 422K 1.9M -5.17M 84K -3.42M -1.15M 424K 1.63M -277K
Shares Outstanding (Basic)
1.08M 1.03M 1.03M 1.03M 1.03M 1.02M 1.02M 1.02M 1.02M 1.02M 1.04M 1.05M 1.04M 1.04M 1.04M 1.04M 1.04M
Shares Outstanding (Diluted)
1.08M 1.03M 1.03M 1.03M 1.03M 1.02M 1.02M 1.02M 1.02M 1.02M 1.04M 1.05M 1.04M 1.04M 1.04M 1.04M 1.04M
EPS (Basic)
-13 -79.8 -33.9 -105.7 -119.2 -155.3 -172.3 -132.1 -181.8 -203.4 -232.1 -253.3 -250.3 -239.4 -163.1 -195.9 -166.9
EPS (Diluted)
-13 -79.8 -33.9 -105.7 -119.2 -155.3 -172.3 -132.1 -181.8 -203.4 -232.1 -253.3 -250.3 -239.4 -163.1 -195.9 -166.9
EBITDA
-15.18M -46.8M -38.59M -111.48M -92.97M -147.79M -148.63M -105.54M -158.27M -187.26M -223.49M -235.38M -251.71M -251.47M -162.93M -191.2M -163.75M
EBIT
-15.18M -46.8M -38.59M -111.22M -125.83M -148.3M -178.81M -135.72M -188.46M -214.32M -234.64M -262.02M -262.86M -252.2M -169.69M -201.47M -170.9M
Depreciation & Amortization
n/a n/a n/a -262K 32.86M 32.86M 30.19M 30.19M 30.19M 30.19M 11.15M 30.08M 11.15M 11.15M 8.11M 10.83M 8.11M